CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

Division of Industry Dynamics Associates

Division of Industry Dynamics Associates is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wilkinson Pharmacy

Wilkinson Pharmacy is a Nevada, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wake Research

Wake Researchs network of high-quality research sites and millions of patients is built on decades of experience meeting the needs of sponsors & CROs.

Nutra Manufacturing

Nutra Manufacturing, Inc is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nipro Medical

Nipro provides premium renal medical devices, including dialyzers, bloodlines, AVF needles, as well as high-quality medical surgical products.